方便，及时访问最新的可靠科学信息是医疗保健从业者（HCP）为患者提供最佳护理能力的关键。lol买外围用什么软件尽管制药制造商每年进行许多医疗活动来解决现有的知识差距，但我们如何知道他们是否满足HCP的需求，从而对患者护理产生积极影响？

In this post, we discuss how to overcome some common challenges faced in developing medical activities and how to ensure investments have maximum impact to improve patient outcomes.

确保内容与每个HCP产生共鸣

Prior to engaging with HCPs, it is helpful to establish a baseline assessment of their awareness and perceptions of new medical information, tools, and strategies. At the same time, it is important to recognize that information gaps may not always reflect a lack of knowledge but may be the result of HCP perceptions and attitudes. Topics that lack immediate relevance for a practitioner may not resonate with them. Using standardized questionnaires and leveraging theoretical constructs, detailed insights can be gleaned that help understand physician perceptions.

Determining awareness and attitudes can articulate learning objectives that HCPs are keen to meet. This can lead to the development of a more targeted medical education program that addresses their areas of interest.

Effectively utilizing limited resources to reach the appropriate audiences

There are myriad communication channels available to engage with HCPs such as virtual meetings, small group meetings, continuing education forums, and conferences, among others. However, it can be costly and not always efficient to leverage these channels and meeting formats. It is key to understand how HCPs prefer to engage with the pharmaceutical organization. This can vary by therapy area and the type of information that is to be disseminated. For example, HCPs may prefer to engage in small group sessions to discuss the results of a pivotal trial among peers, but otherwise favour in-person or virtual one-on-one meetings with medical science liaisons (MSLs) for any additional engagements.

除了会议格式外，注意诸如日期和会议持续时间之类的细节还会影响HCP对提供给他们的信息的接受程度。将这些细节纳入组织的医学教育策略可以确保HCP所花费的时间对HCP和MSL都有价值。

Furthermore, even within the same therapeutic area, HCPs are unlikely to be homogenous. There may be nuances in how individuals prefer to engage with a pharmaceutical organization based on demographic factors such as age, gender, and geography; all factors which can impact delivery of medical education.

Through these insights, pharmaceutical manufacturers can align internal resources, develop strategies, and create actionable tactics to ensure all customer engagements drive value and pave the way for continued collaboration between the medical affairs team and HCPs.

Assessing the broader impact and staying relevant

一旦建立了基线评估，制定了沟通计划，并提供了由此产生的医学教育，重要的是要确定是否达到战略目标。在HCP如何提供患者护理方面，是否进行了可识别的更改？

通过进行后续评估，可以获得见解，以确定HCP的比例是哪些比例获得了与他们相关王者荣耀kpl外围投注的支持和信息。第二阶段可以评估开展的医疗活动的影响。目前，还可以识别任何可能影响HCPS的外部影响，例如竞争对手活动，政策影响或疾病管理中的重大发现。

Armed with this information, subsequent medical activities and MSL engagements can be tailored to ensure relevance. At its core, the relationship a pharmaceutical organization has with its HCPs is essential to drive positive healthcare outcomes for patients. It is critical to measure the overall satisfaction with an organization’s medical outreach activities. If HCPs do not derive value from these initiatives, it is unlikely that any strategies will be impactful.

建立衡量影响的过程

开发一种简化且具有成本效益的解决方案来评估医疗活动的影响将解决所描述的挑战。这包括确定关键问题，问卷调查，受访者的招聘以及洞察力的生成。这些过程可以有效地适用于各种治疗区域和HCP类型，从而使周转时间短。

最终，这些见解支持药物组织通过提供相王者荣耀kpl外围投注关和及时的医学教育并帮助实现阳性患者结果的目标来增强HCP的能力，从而增强患者护理。

有关如何评估组织医疗活动的影响以及IQVIA如何提供帮助的更多信息，请联系calum.neish@iqvia.com.